Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: A systematic review and meta-analysis

Human Reproduction Update

Volumn 24, Issue 5, 2018, Pages 599-614

  Alviggi, Carlo ^a,b   Conforti, Alessandro ^a   Santi, Daniele ^c   Esteves, Sandro C ^d   Andersen, Claus Yding ^e   Humaidan, Peter ^f,g   Chiodini, Paolo ^h   De Placido, Giuseppe ^a   Simoni, Manuela ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e Mental Health Services CPH   (Denmark)

^f SKIVE REGIONAL HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY   (Denmark)

^h SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Assisted reproduction; FSH; Gonadotrophins; LH; Ovarian stimulation; Pharmacogenomics; Polymorphisms

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE BETA SUBUNIT; LUTEINIZING HORMONE RECEPTOR;

ARTICLE; CELL COUNT; CLINICAL PRACTICE; CONTROLLED OVARIAN STIMULATION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; META ANALYSIS; METAPHASE; OOCYTE; OOCYTE RETRIEVAL; OVULATION INDUCTION; PHARMACOGENOMICS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; GENETICS; PHARMACOGENETIC VARIANT;

FEMALE; FOLLICLE STIMULATING HORMONE; GENOTYPE; GONADOTROPINS; HUMANS; LUTEINIZING HORMONE; OVULATION INDUCTION; PHARMACOGENOMIC VARIANTS; RECEPTORS, FSH; RECEPTORS, LH;

EID: 85052520386     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmy019     Document Type: Article

References (74)

1. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Folliclestimulating hormone receptor polymorphism (Thr307Ala) is associated with variable ovarian response and ovarian hyperstimulation syndrome in Indian women. Fertil Steril 2009a;91:432-439
2. Achrekar SK, Modi DN, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism. Reprod Biomed Online 2009b;18:509-515
3. Almawi WY, Hubail B, Arekat DZ, Al-Farsi SM, Al-Kindi SK, Arekat MR, Mahmood N, Madan S. Leutinizing hormone/choriogonadotropin receptor and follicle stimulating hormone receptor gene variants in polycystic ovary syndrome. J Assist Reprod Genet 2015;32:607-614
4. Altmae S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update 2011;17:813-828
5. Alviggi C, Mollo A, Clarizia R, De Placido G. Exploiting LH in ovarian stimulation. Reprod Biomed Online 2006;12:221-233
6. Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, Coppola M, Ranieri A, D'uva M, De Placido G. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online 2011;22: S67-S72
7. Alviggi C, Conforti A, Caprio F, Gizzo S, Noventa M, Strina I, Pagano T, De Rosa P, Carbone F, Colacurci N et al. In estimated good prognosis patients could unexpected 'Hyporesponse' to controlled ovarian stimulation be related to genetic polymorphisms of FSH receptor? Reprod Sci 2016a;23:1103-1108
8. Alviggi C, Conforti A, Cariati F, Alfano S, Strina I, Huhtaniemi I, Humaidan P. Abstracts of the 32nd Annual Meeting of the European Society of Human Reproduction and Embryology. Hum Reprod 2016b;31:i1-i513
9. Alviggi C, Conforti A, Esteves SC. Impact of mutations and polymorphisms of gonadotrophins and their receptors on the outcome of controlled ovarian stimulation. In: Ghumman S (ed). Principles and Practice of Controlled Ovarian Stimulation in ART. New Delhi, India: Springer, 2015;147-156
10. Alviggi C, Conforti A, Fabozzi F, De Placido G. Ovarian stimulation for IVF/ICSI cycles: a pharmacogenomic approach. MT médecine de la reproduction, gynécologie, endocrinologie 2009;11:271-277
11. Alviggi C, Pettersson K, Longobardi S, Andersen CY, Conforti A, De Rosa P, Clarizia R, Strina I, Mollo A, De Placido G et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol 2013;11:51
12. Anagnostou E, Mavrogianni D, Theofanakis C, Drakakis P, Bletsa R, Demirol A, Gurgan T, Antsaklis A, Loutradis D. ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Curr Pharm Biotechnol 2012;13:426-434
13. Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwaßer P, Seliger E, Röpke F, Gromoll J, Nieschlag E et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics 2005;15:451-456
14. Borgbo T, Jeppesen JV, Lindgren I, Lundberg Giwercman Y, Hansen LL, Yding Andersen C. Effect of the FSH receptor single nucleotide polymorphisms (FSHR 307/680) on the follicular fluid hormone profile and the granulosa cell gene expression in human small antral follicles. Mol Hum Reprod 2015;21:255-261
15. Boudjenah R, Molina-Gomes D, Torre A, Boitrelle F, Taieb S, Dos Santos E, Wainer R, De Mazancourt P, Selva J, Vialard F. Associations between individual and combined polymorphisms of the TNF and VEGF genes and the embryo implantation rate in patients undergoing in vitro fertilization (IVF) programs. PLoS One 2014;9:e108287
16. Casarini L, Moriondo V, Marino M, Adversi F, Capodanno F, Grisolia C, La Marca A, La Sala GB, Simoni M. FSHR polymorphism p.N680S mediates different responses to FSH in vitro. Mol Cell Endocrinol 2014;393:83-91
17. Casarini L, Santi D, Marino M. Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success. Reproduction 2015;150:R175-R184
18. Colognato R, Aiello R, Dulcetti F, Ruggeri AM, De Toffol S, Marcato L, Irollo AM, Criscuolo C, Gangale MF, Maggi F et al. A pharmacogenetic-driven approach for controlled ovarian hyperstimulation by FSH treatment. Minerva Ginecol 2014;66: 543-549
19. Daelemans C, Smits G, De Maertelaer V, Costagliola S, Englert Y, Vassart G, Delbaere A. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J Clin Endocrinol Metab 2004;89:6310-6315
20. Dan W, Jing G, Liangbin X, Ting Z, Ying Z. Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients. Iran J Reprod Med 2015;13:715-720
21. Davar R, Tabibnejad N, Kalantar SM, Sheikhha MH. The luteinizing hormone betasubunit exon 3 (Gly102Ser) gene mutation and ovarian responses to controlled ovarian hyperstimulation. Iran J Reprod Med 2014;12:667-672
22. De Castro F, Morón FJ, Montoro L, Galán JJ, Pérez-Hernández D, Sánchez-Casas Padilla E, Ramírez-Lorca R, Real LM, Ruiz A. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 2004;14:285-293
23. De Castro F, Ruiz R, Montoro L, Pérez-Hernández D, Sánchez-Casas Padilla E, Real LM, Ruiz A. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril 2003;80:571-576
24. Desai SS, Achrekar SK, Paranjape SR, Desai SK, Mangoli VS, Mahale SD. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod Biomed Online 2013;27:400-406
25. Desai SS, Achrekar SK, Pathak BR, Desai SK, Mangoli VS, Mangoli RV, Mahale SD. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab 2011;96:2805-2812
26. Duval S. The Trim and Fill Method. In: Rothstein HR, Sutton AJ, Borenstein M (eds). Publication Bias in Meta-Analysis. The Atrium, Southern Gate, Chichester, West Sussex, England: John Wiley & Sons, Ltd, 2006;127-144
27. D'alva CB, Serafini P, Motta E, Kohek MB, Latronico AC, Mendonca BB. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome. Fertil Steril 2005;83:1695-1699
28. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634
29. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC, Foresta C. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril 2011;96:1344-1349.e2
30. Genro VK, Matte U, De Conto E, Cunha-Filho JS, Fanchin R. Frequent polymorphisms of FSH receptor do not influence antral follicle responsiveness to folliclestimulating hormone administration as assessed by the Follicular Output RaTe (FORT). J Assist Reprod Genet 2012;29:657-663
31. Greb RR, Behre HM, Simoni M. Pharmacogenetics in ovarian stimulation-current concepts and future options. Reprod Biomed Online 2005;11:589-600
32. Grigorova M, Punab M, Poolamets O, Kelgo P, Ausmees K, Korrovits P, Vihljajev V, Laan M. Increased prevalance of the-211 T allele of follicle stimulating hormone (FSH) beta subunit promoter polymorphism and lower serum FSH in infertile men. J Clin Endocrinol Metab 2010;95:100-108
33. Haavisto AM, Pettersson K, Bergendahl M, Virkamaki A, Huhtaniemi I. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab 1995;80:1257-1263
34. Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR O'donovan MC. Functional analysis of human promoter polymorphisms. Hum Mol Genet 2003;12:2249-2254
35. Huang X, Li L, Hong L, Zhou W, Shi H, Zhang H, Zhang Z, Sun X, Du J. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation. Clin Endocrinol (Oxf) 2015;82:577-583
36. Huang S, Yang J, Yin T, Xing LI, Jie LI, Xu W. Association of gene polymorphism of follicle stimulating hormone receptor with ovarian response in IVF cycles. Med J Wuhan Univ 2010;31:334-338
37. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome. F1000Res 2016;5:2911
38. John M, Lencz T, Malhotra AK, Correll CU, Zhang JP. A simulations approach for meta-analysis of genetic association studies based on additive genetic model. Meta Gene 2018;16:143-164
39. Jun JK, Yoon JS, Ku SY, Choi YM, Hwang KR, Park SY, Lee GH, Lee WD, Kim SH, Kim JG et al. Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet 2006;51:665-670
40. Klinkert ER, Te Velde ER, Weima S, Van Zandvoort PM, Hanssen RG, Nilsson PR, De Jong FH, Looman CW, Broekmans FJ. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online 2006;13:687-695
41. La Marca A, Papaleo E, Alviggi C, Ruvolo G, De Placido G, Candiani M, Cittadini E, De Michele F, Moriondo V, Catellani V et al. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod 2013;28:1369-1374
42. Laisk-Podar T, Kaart T, Peters M, Salumets A. Genetic variants associated with female reproductive ageing-potential markers for assessing ovarian function and ovarian stimulation outcome. Reprod Biomed Online 2015;31:199-209
43. Laven JS, Mulders AG, Suryandari DA, Gromoll J, Nieschlag E, Fauser BC, Simoni M. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility. Fertil Steril 2003;80:986-992
44. Lazaros LA, Hatzi EG, Pamporaki CE, Sakaloglou PI, Xita NV, Markoula SI, Stefos TI, Zikopoulos KA, Georgiou IA. The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism. J Assist Reprod Genet 2012;29:1185-1191
45. Lazaros L, Hatzi E, Xita N, Takenaka A, Sofikitis N, Zikopoulos K, Georgiou I. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI. J Reprod Med 2013;58:395-401
46. Lindgren I, Baath M, Uvebrant K, Dejmek A, Kjaer L, Henic E, Bungum M, Bungum L, Cilio C, Leijonhufvud I et al. Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization. Hum Reprod 2016;31:672-683
47. Livshyts G, Podlesnaja S, Kravchenko S, Sudoma I, Livshits L. A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine. J Assist Reprod Genet 2009;26:29-34
48. Lledo B, Guerrero J, Turienzo A, Ortiz JA, Morales R, Ten J, Llacer J, Bernabeu R. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics 2013;23:262-268
49. Lledó B, Dapena P, Ortiz JA, Morales R, Llacer J, Bernabeu R. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to folliclestimulating hormone receptor genotype. Pharmacogenet Genomics 2016;26:288-293
50. Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, Makrigiannakis A. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet 2006;23:177-184
51. Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Basak N, Bohm R, Borg J, Borgiani P, Bozina N et al. A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics. PLoS One 2016;11:e0162866
52. Mohiyiddeen L, Nardo LG. Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF. Hum Fertil (Camb) 2010;13:72-78
53. Mohiyiddeen L, Newman WG, Cerra C, Horne G, Mulugeta B, Byers H, Roberts SA, Nardo LG. FSH receptor genotype does not predict metaphase-II oocyte output or fertilization rates in ICSI patients. Reprod Biomed Online 2013a; 27:305-309
54. Mohiyiddeen L, Newman WG, Cerra C, Mcburney H, Mulugeta B, Roberts SA, Nardo LG. A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertil Steril 2013b;99:149-155
55. Nakayama T, Kuroi N, Sano M, Tabara Y, Katsuya T, Ogihara T, Makita Y, Hata A, Yamada M, Takahashi N et al. Mutation of the follicle-stimulating hormone receptor gene 5'-untranslated region associated with female hypertension. Hypertension 2006;48:512-518
56. Nilsson C, Pettersson K, Millar RP, Coerver KA, Matzuk MM, Huhtaniemi IT. Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertil Steril 1997;67:998-1004
57. Nilsson C, Jiang M, Pettersson K, Iitia A, Makela M, Simonsen H, Easteal S, Herrera RJ, Huhtaniemi I. Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxf) 1998;49: 369-376
58. Nordhoff V, Sonntag B, Von Tils D, Gotte M, Schuring AN, Gromoll J, Redmann K, Casarini L, Simoni M. Effects of the FSH receptor gene polymorphism p.N680S on cAMP and steroid production in cultured primary human granulosa cells. Reprod Biomed Online 2011;23:196-203
59. O'brien TJ, Kalmin MM, Harralson AF, Clark AM, Gindoff I, Simmens SJ, Frankfurter D, Gindoff P. Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reprod Biol Endocrinol 2013;11:71
60. Patel V, Lin FJ, Ojo O, Rao S, Yu S, Zhan L, Touchette DR. Cost-utility analysis of genotype-guided antiplatelet therapy in patients with moderate-to-high risk acute coronary syndrome and planned percutaneous coronary intervention. Pharm Pract (Granada) 2014;12:438
61. Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab 2000;85:3365-3369
62. Poseidon G, Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, Esteves SC, Fischer R, Galliano D, Polyzos NP et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril 2016;105:1452-1453
63. Sheikhha MH, Eftekhar M, Kalantar SM. Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation. J Hum Reprod Sci 2011;4:86-90
64. Simoni M, Casarini L. Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol 2014;170:R91-R107
65. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod 2002;8:893-899
66. Sychev DA, Malova EU. Evidence-based pharmacogenetics: is it possible? Int J Risk Saf Med 2015;27:S97-S98
67. Tohlob D, Abo Hashem E, Ghareeb N, Ghanem M, Elfarahaty R, Byers H, Pemberton P, Roberts SA, Newman WG, Mohiyiddeen L. Association of a promoter polymorphism in FSHR with ovarian reserve and response to ovarian stimulation in women undergoing assisted reproductive treatment. Reprod Biomed Online 2016;33:391-397
68. Trevisan CM, Peluso C, Cordts EB, De Oliveira R, Christofolini DM, Barbosa CP, Bianco B. Ala307Thr and Asn680Ser polymorphisms of FSHR gene in human reproduction outcomes. Cell Physiol Biochem 2014;34:1527-1535
69. Valkenburg O, Van Santbrink EJ, Konig TE, Themmen AP, Uitterlinden AG, Fauser BC, Lambalk CB, Laven JS. Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility. Fertil Steril 2015;103:1081-1088.e3
70. Wells G, Shea B, O'connell D, Peterson J, Welch V, Losos M, Tugwell P Quality Assessment Scales for Observational Studies. Ottawa Health Research Institute 2004
71. Yan Y, Gong Z, Zhang L, Li Y, Li X, Zhu L, Sun L. Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study. PLoS One 2013;8:e78138
72. Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab 2011;103:388-393
73. Yin Q, Li Y, Huang J, Yang D. [Association of rs13405728 polymorphism of LHR gene with slow ovarian response]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2015; 32:840-843
74. Zalewski G, Wolczynski S, Chyczewski L. Association of rs6166 polymorphism with FSH receptor transcript variants and steroid production in human granulosa cell cultures. Syst Biol Reprod Med 2013;59:191-198